rs1554327284
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001129.5(AEBP1):c.1320_1326del(p.Arg440SerfsTer3) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
AEBP1
NM_001129.5 frameshift
NM_001129.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.05
Genes affected
AEBP1 (HGNC:303): (AE binding protein 1) This gene encodes a member of carboxypeptidase A protein family. The encoded protein may function as a transcriptional repressor and play a role in adipogenesis and smooth muscle cell differentiation. Studies in mice suggest that this gene functions in wound healing and abdominal wall development. Overexpression of this gene is associated with glioblastoma. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-44110261-GCCAGGAC-G is Pathogenic according to our data. Variant chr7-44110261-GCCAGGAC-G is described in ClinVar as [Pathogenic]. Clinvar id is 545024.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr7-44110261-GCCAGGAC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AEBP1 | NM_001129.5 | c.1320_1326del | p.Arg440SerfsTer3 | frameshift_variant | 11/21 | ENST00000223357.8 | |
AEBP1 | XM_011515162.2 | c.1242_1248del | p.Arg414SerfsTer3 | frameshift_variant | 10/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AEBP1 | ENST00000223357.8 | c.1320_1326del | p.Arg440SerfsTer3 | frameshift_variant | 11/21 | 1 | NM_001129.5 | P1 | |
AEBP1 | ENST00000434445.1 | p.Arg1SerfsTer? | coding_sequence_variant, 5_prime_UTR_variant, NMD_transcript_variant | 1/4 | 5 | ||||
AEBP1 | ENST00000453052.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Ehlers-Danlos syndrome, classic-like, 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 30, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at